Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Lorrex Liquicaps (General sale)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Lorrex Liquicaps (Pharmacy only)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Medix Loperamide Liquicaps (General sale)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Medix Loperamide Liquicaps (Pharmacy only)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Nucala
Mepolizumab 144mg
Powder for injection
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Manufacturing SpA, Parma, Italy
|
Dated this 19th day of June 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz